JOSLIN… Just the sound of it makes the heart of most PWDs (people with diabetes) skip a beat. It stands for the world’s leading center for diabetes research, clinical care and education based in Boston, MA. It also harkens back to its namesake founder, Dr. Elliott Joslin, regarded as the father of modern diabetes care.
Ever wonder who currently heads up this amazing place? And what exactly they are doing to bring this Century-old institution…
Read more »
By
AmyT on
March 14, 2013
From the “crap no one ever tells you about with diabetes” file, comes:
Dissect the word with me for a moment:
Lipo — OK, that sounds like weight loss surgery.
Hyper — Yes, we often are. How else could we juggle work, kids, exercise, myriad lab tests and doctor’s appointments, non-stop carb-counting and dosing adjustments, etc., etc. and still do our taxes?
Trophy — Do I get one, for putting up with all this diabetes…
Read more »
By
AmyT on
February 18, 2013
When type 1 journalist Jim Hirsch came out with his book about the business and life-challenges of diabetes, Cheating Destiny, I called it the book I wish I wrote; it moved and entertained me, and it felt like the first-ever book about diabetes that people without the disease could ever truly enjoy reading.
Now comes attorney Amy Ryan’s new volume Shot: Staying Alive With Diabetes, which feels like the book that I DID WRITE —…
Read more »
By
MikeH on
February 5, 2013
Many in the Diabetes Community are anxiously awaiting the release of the smaller and sleeker 2nd generation OmniPod, but already we know what a third generation won’t have:
A Pod that’s integrated with a Dexcom CGM sensor.
Yep, it’s true: the two companies say they have abandoned the integration deal they had in place since 2008.
Two executives at Massachusetts-based Insulet Corp., makers of the OmniPod, say they’re no longer working with California-based Dexcom on…
Read more »
By
MikeH on
January 8, 2013
In the world of diabetes devices, company execs, PR pros, sales reps and even doctors are often vague about when new products will hit the market and be available for us people with diabetes. They tout new tools “coming soon” without any specificity as to when a product might actually be available. And on message boards frequented by patients, rumors can fly.
After an exciting year of new diabetes product approvals in 2012, we wanted…
Read more »
